If it works, we pay. If not, we get most — if not all — of our money back. That’s the gist of a deal the Massachusetts Medicaid program, MassHealth, has reached for one of the most expensive drugs on the market.
Trending:
Mass. outlines deal for a $2 million drug: Pay only if it works